Buscar resultados de ensayos clínicos
Ewing Sarcoma - 29 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Phase I Study of Olaprib and Temozolomide for Ewings Sarcoma Condición: Ewing Sarcoma Fecha: 2013-05-08 Intervenciones:
|
Withdrawn |
Nombre del estudio: Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients Condición: Ewing's Sarcoma Fecha: 2012-11-19 Intervenciones: Radiation: External Beam Radiotherapy |
Recruiting |
Nombre del estudio: Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma Condición: Ewing's Sarcoma Fecha: 2016-04-04 Intervenciones: Biological: pbi-shRNA™ EWS/FLI1 Type 1 LPX Other Name: pbi-shRNA™ EWS/FLI1 Type 1 Lipoplex |
Completed |
Nombre del estudio: Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma Condición: Ewing's Sarcoma Fecha: 2012-04-18 Intervenciones: Drug: Olaparib 400mg PO BID Continuous Other Name: A |
Recruiting |
Nombre del estudio: ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide or Irinotecan in Patients With Previously Treated, Incurable Ewing Sarcoma Condición: Ewing Sarcoma Fecha: 2014-01-21 Intervenciones:
|
Completed |
Nombre del estudio: Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma Condición:
|
Recruiting |
Nombre del estudio: Protocol for the Treatment of Metastatic Ewing Sarcoma Condición: Ewing's Sarcoma (ES) Fecha: 2016-03-23 Intervenciones:
|
Completed |
Nombre del estudio: Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors Condición: Ewing's Sarcoma Family of Tumors Fecha: 2007-11-15 Intervenciones: Drug: CP-751,871 Final dose 30 mg/kg IV on Day 1 of each 28 day cycle until either progression or toxici |
Recruiting |
Nombre del estudio: Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma Condición: Newly Diagnosed Ewing Sarcoma Fecha: 2013-05-23 Intervenciones:
|
Recruiting |
Nombre del estudio: First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years Condición: Ewing Sarcoma Family of Tumors Fecha: 2016-12-06 Intervenciones:
|